IC50 is typically determined through in vitro experiments. Cancer cells are treated with various concentrations of the drug, and cell viability is assessed after a specific period. The concentration at which 50% of the cells are inhibited is then calculated using a dose-response curve. Cell viability assays such as the MTT assay, CellTiter-Glo, or Alamar Blue are commonly used for this purpose.
